Skip to main content
ADGM
NASDAQ Life Sciences

Adagio Medical Posts Zero Third-Quarter Revenue as Cash Crisis Deepens

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.737
Mkt Cap
$1.765M
52W Low
$1.5
52W High
$50.7
52W Position info
16% above low
Off High info
97% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

ADGM sits 16% above its 52-week low of $1.5 on light trading volume (0.4× avg).

Summary

Adagio Medical reported $0.00 in third-quarter revenue, confirming the commercial engine has stalled while the company burns through a dwindling cash pile, and posted a third-quarter loss per share of $5.13. The zero top line lands after a brutal stretch: the board opened a strategic alternatives process including a possible sale on September 23, alongside a 58% workforce reduction, and the company has already executed a 1-for-30 reverse split on November 6 to hold its Nasdaq listing. Cash stood at $7.7M at the last 10-Q with a going concern warning and runway only into Q4 2026, so a quarter with no revenue sharpens the liquidity clock considerably. Days after the reverse split the company filed a new proxy seeking approval for another reverse split of up to 1-for-1,000 — a sign management sees continued listing pressure rather than a fix. The strategic alternatives process is the live event; any announcement of a buyer, merger partner, or financing is what changes the story from here.

At the time of this announcement, ADGM was trading at $1.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.50 to $50.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADGM - Latest Insights

ADGM
Nov 16, 2026, 8:04 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $1.61 info
Change: -$0.1269 (-7%) info
Market Cap: $1.473M info
ADGM
Nov 16, 2026, 8:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.61 info
Change: -$0.1269 (-7%) info
Market Cap: $1.473M info
ADGM
Nov 10, 2026, 5:30 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $1.84
Real-time Price: $1.61 info
Change: -$0.230 (-12%) info
Market Cap: $1.473M info
ADGM
Oct 01, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1535
Real-time Price: $1.61 info
Change: Reverse Stock Split info
Market Cap: $1.473M info
ADGM
Oct 01, 2026, 4:54 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.1544
Real-time Price: $1.61 info
Change: Reverse Stock Split info
Market Cap: $1.473M info